Horm Metab Res 1993; 25(8): 430-433
DOI: 10.1055/s-2007-1002138
Originals Clinical

© Georg Thieme Verlag, Stuttgart · New York

Evaluation of Thyrotropin Secretion Before and After TRH by Third Generation Chemiluminescent Assay

Assessment of Subclinical HyperthyroidismL. Duntas1 , B. M. Grab2 , J. E. Dominguez-Munoz1 , D. K. Nelson1 , 3 , U. Loos1 , F. S. Keck1
  • 1Abteilung Innere Medizin I und
  • 2Abteilung Nuklear Medizin, Universität Ulm, Ulm, Germany
  • 3Mayo Clinic, Rochester, Minnesota, U.S.A.
Further Information

Publication History

1992

1993

Publication Date:
14 March 2008 (online)

Summary

The recent introduction of third generation assays for TSH has led to a considerable improvement of assay sensitivity. To assess the clinical significance of subnormal basal TSH (b-TSH) values (< 0.2 μU/ml), we investigated b-TSH and TRH-stimulated TSH (r-TSH) by means of a new, highly sensitive immunochemiluminometric assay in 105 euthyroid subjects, 45 patients with overt hyperthyroidism and 18 patients suspected of having subclinical hyperthyroidism. A weak, albeit statistically significant, correlation (r=0.48) was found between b-TSH and r-TSH and also between b-TSH and δ-TSH (r=0.31) in euthyroid subjects. Consideration of b-TSH alone correctly identified 90 % of euthyroid subjects in this group; 10 of 105 apparently euthyroid subjects presented δ-TSH suggesting subclinical hyperthyroidism. While b-TSH was detectable (> 0.04 μU/ ml) in 8 of 45 (18 %) of hyperthyroid patients, all (100 %) were abnormal in both b-TSH and r-TSH. 14 of 18 (78 %) of patients with subclinical hyperthyroidism exhibited a blunted TSH response to stimulation (δ-TSH < 2 μU/ml). These results suggest that although the new generation of TSH assays can be a valuable addition to the diagnostic arsenal of thyroid function tests, certain limitations must still be accepted. Specifically, b-TSH in the “grey zone” (0.1 - 0.2 μU/ml) appears to be a less than reliable predictor of thyroid function.

    >